Skip to content
Regenxbio logo

Regenxbio

RGNXNASDAQStock Fundamentals

Regenxbio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Curran Simpson, with a market cap of $324.7M.

Market Cap$324.7M
Employees344.0
CEOCurran Simpson
United States of America flag
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 1 month agoQ1 2026
View report
Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Regenxbio logo

Regenxbio FAQ

Common questions about Regenxbio

Regenxbio (RGNX) has a market capitalization of $324.7M and trades on NASDAQ.

Regenxbio has approximately 344 employees.